Micro- and Nanoscale Approaches in Antifungal Drug Discovery
AbstractClinical needs for novel antifungal agents have increased due to the increase of people with a compromised immune system, the appearance of resistant fungi, and infections by unusual yeasts. The search for new molecular targets for antifungals has generated considerable research, especially using modern omics methods (genomics, genome-wide collections of mutants, and proteomics) and bioinformatics approaches. Recently, micro- and nanoscale approaches have been introduced in antifungal drug discovery. Microfluidic platforms have been developed, since they have a number of advantages compared to traditional multiwell-plate screening, such as low reagent consumption, the manipulation of a large number of cells simultaneously and independently, and ease of integrating numerous analytical standard operations and large-scale integration. Automated high-throughput antifungal drug screening is achievable by massive parallel processing. Various microfluidic antimicrobial susceptibility testing (AST) methods have been developed, since they can provide the result in a short time-frame, which is necessary for personalized medicine in the clinic. New nanosensors, based on detecting the nanomotions of cells, have been developed to further decrease the time to test antifungal susceptibility to a few minutes. Finally, nanoparticles (especially, silver nanoparticles) that demonstrated antifungal activity are reviewed. View Full-Text
Share & Cite This Article
Willaert, R.G. Micro- and Nanoscale Approaches in Antifungal Drug Discovery. Fermentation 2018, 4, 43.
Willaert RG. Micro- and Nanoscale Approaches in Antifungal Drug Discovery. Fermentation. 2018; 4(2):43.Chicago/Turabian Style
Willaert, Ronnie G. 2018. "Micro- and Nanoscale Approaches in Antifungal Drug Discovery." Fermentation 4, no. 2: 43.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.